# Bristol-Myers Squibb Company (BMY) — Q2-2024 Earnings Results

**Report date:** 2024-07-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Bristol-Myers Squibb Beats on EPS, Stock Up 11.44%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.07 | N/A | +26.53% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Bristol-Myers Squibb reported a strong earnings per share, exceeding expectations significantly. The stock reacted positively, rising by 11.44%, likely driven by investor confidence in the company's performance despite the lack of revenue data and management commentary.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2024_